Recent Posts
- Industry Veteran John Yee, MD, MPH Joins ReForm Biologics Board of Directors
- Absci IPO
- How Sean McClain founded Absci at just 22 — and now leads a newly public biotech worth nearly $2B
- Inkbit Raises $30M in Series B Funding, Plans to Expand Production of 3D Printing System
- From basement lab to Wall Street: Absci looks to bring its ‘protein printing’ platform public